Allena Pharmaceuticals Inc organizacji EV/EBIT
Jaka jest wartość EV/EBIT organizacji Allena Pharmaceuticals Inc?
Wartość EV/EBIT organizacji Allena Pharmaceuticals Inc to N/A
Jaka jest definicja EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT firm w Health Care sektor na NASDAQ w porównaniu do Allena Pharmaceuticals Inc
Firmy z ev/ebit podobne do Allena Pharmaceuticals Inc
- Wartość EV/EBIT organizacji Hi Crush Inc to N/A
- Wartość EV/EBIT organizacji Cocrystal Pharma Inc to N/A
- Wartość EV/EBIT organizacji Panorama Capital to N/A
- Wartość EV/EBIT organizacji Nuverra Environmental Solutions Inc to N/A
- Wartość EV/EBIT organizacji Touchpoint to N/A
- Wartość EV/EBIT organizacji Equity Metals to N/A
- Wartość EV/EBIT organizacji Allena Pharmaceuticals Inc to N/A
- Wartość EV/EBIT organizacji Queen's Road Capital Investment to N/A
- Wartość EV/EBIT organizacji Uxin Ltd to N/A
- Wartość EV/EBIT organizacji Red Light Holland to N/A
- Wartość EV/EBIT organizacji St. James Gold to N/A
- Wartość EV/EBIT organizacji Eat Beyond Global to N/A
- Wartość EV/EBIT organizacji Consolidated Firstfund Capital to N/A